Ballicules.com

Triazolam

HALCION

What it isUltra-short-acting benzodiazepine; sleep-onset insomnia.

Why this oneThe shortest action of the benzodiazepine hypnotics, so morning residue is minimal.

What limits itAnterograde amnesia and rebound insomnia are prominent. CYP3A4-dependent; dependence as for the class.

FDA-approved for

FDA label

BOXED WARNING Risks from concomitant use with opioids; abuse, misuse, and addiction; dependence and withdrawal reactions
FDA dosingPopulationStartTargetMax
Insomnia (short-term)Adults0.25 mg QHS0.25 mg QHS0.5 mg QHS
Insomnia (short-term)Geriatric0.125 mg QHS0.125–0.25 mg QHS0.25 mg QHS

Renal Undefined

Hepatic Undefined

Instructions

Contraindications

Cautions

Adverse reactions

Pregnancy No clear association with major birth defects; late-pregnancy use can cause neonatal sedation and/or withdrawal

Lactation No human milk data; benzodiazepines linked to infant sedation/poor feeding; may pump and discard for 28 hours after a dose

⚠ BOXED WARNINGS

Cost, est. cash$10–$300/month

Generic entry1994

Classes and tags

Clinical profile

Therapeutic safety burden2 / 4
Overdose danger2 / 4
Weight-gain liability0 / 4
Sedation liability3 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk2 / 4

Legacy pregnancy categoryX

Defining liabilitySedation, falls, dependence and additive respiratory depression with opioids or other CNS depressants.

Mechanism of action: Triazolam ballicule

Triazolam ballicule: receptor binding, kinetics and half-life diagram

Open Triazolam in the interactive console ↗

Memory aids: mascots and interaction avatars

Triazolam HALCION mascot mnemonic cartoon
“HAL Tries lamenting”
HAL 9000 from 2001: A Space Odyssey
hot pink → benzo theme
Triazolam CYP3A4 substrate avatar
CYP3A4 substrate

Open Triazolam in the interactive console ↗